Follow
Immunology coronavirus
When a person is infected with a coronavirus such as SARS-CoV2, the immune system produces antibodies against a component in the virus. In the case of COVID-19 infections, the SARS-CoV2 virus is made up of RNA surrounded by spike proteins. The spike proteins latch onto cells within the infected individual and the viral RNA replicates allowing the virus to spread and infect more cells. To combat the coronavirus, the immune system must recognize the spike proteins and begin producing antibodies in response.
APR 19, 2021 | 8:00 AM
Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
APR 14, 2021 | 9:00 AM
Date: April 14, 2021 Time: 9:00am PDT Testing solutions for CoV-2 have had to evolve as the pandemic creates challenges and opportunities for various technologies to support the ongoing nee...
APR 14, 2021 | 12:00 AM
Over a year into the COVID-19 pandemic, key vulnerable populations in the United States and across the world lack access to effective vaccines. IDRI has developed technology that addresses s...
MAR 29, 2021 | 8:00 AM
Learning Objectives: Discuss Respiratory Disease State and Current Trends Overview Discuss the Alinity m Resp-4-Plex Assay Design Discuss Alinity m Resp-4-Plex Assay Clinical Performance...
MAR 16, 2021 | 8:00 AM
DATE: March 09, 2021 TIME: 08:00am PST The COVID-19 pandemic has placed urgency on precise analysis of rare antigen- and virus-specific T cells. At Miltenyi Biotec, we offer a complete workf...
FEB 10, 2021 | 8:00 AM
Date: February 10, 2021 Time: 8:00am (PST), 11:00am (EST) Uncovering the interactions between the immune system and cancer cells or pathogens is key for understanding and controlling both ca...
DEC 11, 2020 | 7:00 AM
Date: November 16, 2020 Time: 7:00am (PST), 10:00am (EST) Join us for a webinar to learn about quality control (QC) regulations, setting the proper QC strategy/design, and troubleshoot SARs...
DEC 03, 2020 | 4:30 PM
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
DEC 03, 2020 | 3:00 PM
The presentation will provide a review of major emerging zoonotic virus outbreaks from Hendra virus in 1994 in Australia to SARS-CoV-2 in China 2019 and our latest findings on bat biology an...
DEC 03, 2020 | 1:30 PM
The University of Louisville Infectious Diseases Laboratory (IDL) is a high-complexity, CLIA-certified laboratory in Louisville, KY. The IDL adopted the Luminex ARIES® platform in 2016 f...
DEC 03, 2020 | 10:30 AM
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 and has spread globally, causing a pandemic of respiratory illness designated coronavirus disease 20...
DEC 03, 2020 | 12:00 AM
SARS-CoV-2 had spread with speed unknown in recent history across the globe, sickening >50M people and killing over 1M. By far the most of the severe cases and deaths were registered amon...
DEC 03, 2020 | 12:00 AM
Next-Generation Sequencing (NGS) has been a key technology during the COVIID-19 pandemic and has helped researchers characterize the SARs-CoV-2 genome, perform strain-typing for molecular ep...
